Nanodigmbio – Expert in Targeted NGS Solutions
Nanodigmbio is a leading provider of high-quality targeted sequencing solutions, dedicated to delivering ready-to-use products for academic institutions, medical centers, and NGS-related biotech companies. The company offers a comprehensive range of library preparation kits and liquid-phase hybridization reagents, fully compatible with Illumina and MGI platforms.
Nanodigmbio’s optimized NGS panels support both precision medicine and cutting-edge research, including Exome Research Panels, Pan-Cancer Panels, Hematologic Oncology Panels, and Respiratory Virus Panels. The company also specializes in custom panel development, which is rigorously validated by NGS to meet diverse project needs.
With a state-of-the-art R&D center of over 2,000 m² and a GMP-certified manufacturing facility of over 4,000 m² (ISO 13485:2016), Nanodigmbio ensures continuous innovation and top-tier production quality. Its sales network spans across China and is rapidly expanding into global markets. Nanodigmbio is proud to grow alongside its international partners, striving to meet all demands for high-quality targeted sequencing solutions and related IVD materials.